CoChat

Selective vulnerability in Alzheimer's disease: Amyloid precursor protein and p75NTR interaction

Open access
Fombonne, Joanna, Rabizadeh, Shahrooz, Banwait, Surita, Mehlen, Patrick, Bredesen, Dale E. · 2009 · Annals of Neurology
Cited by 69

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Objective: Selective neuronal vulnerability in neurodegenerative diseases is poorly understood. In Alzheimer's disease, the basal forebrain cholinergic neurons are selectively vulnerable, putatively because of their expression of the cell death mediator p75 NTR (the common neurotrophin receptor), and its interaction with proapoptotic ligands pro–nerve growth factor and amyloid‐β peptide. However, the relation between amyloid precursor protein (APP) and p75 NTR has not been described previously. Methods: APP and p75 NTR were assayed for interaction by coimmunoprecipitation in vitro and in vivo, yeast two‐hybrid assay, bioluminescence resonance energy transfer, and confocal microscopy. Effects on APP processing and signaling were studied using immunoblotting, enzyme‐linked immunosorbent assays, and luciferase reporter assays. Results: The results of this study are as follows: (1) p75 NTR and APP interact directly; (2) this interaction is modified by ligands nerve growth factor and β‐amyloid; (3) APP and p75 NTR colocalization in vivo is modified in Alzheimer's model transgenic mice; (4) APP processing is altered by p75 NTR, and to a lesser extent, p75 NTR processing is altered by the presence of APP; (5) APP‐dependent transcription mediated by Fe65 is blocked by p75 NTR; and (6) coexpression of APP and p75 NTR triggers cell death. Interpretation: These results provide new insight into the emerging signaling network that mediates the Alzheimer's phenotype and into the mechanism of basal forebrain cholinergic neuronal selective vulnerability. In addition, the results argue that the interaction between APP and p75 NTR may represent a therapeutic target in Alzheimer's disease. Ann Neurol 2009;65:294–303

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.21578

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 69

Metadata

Authors
Fombonne, J., Rabizadeh, S., Banwait, S., Mehlen, P., & Bredesen, D. E.
Venue
Annals of Neurology
Publisher
Wiley
Published
2009-03
Volume
65
Issue
3
Pages
294-303
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W2111842613
Cited by
69
References
5
FWCI
4.13
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Selective vulnerability in Alzheimer's disease: Amyloid precursor protein and p75NTR interaction. https://app.cochat.ai/papers/10.1002/ana.21578
The paper
Fombonne, J., Rabizadeh, S., Banwait, S., Mehlen, P., & Bredesen, D. E. (2009). Selective vulnerability in Alzheimer's disease: Amyloid precursor protein and p75NTR interaction. Annals of Neurology. https://doi.org/10.1002/ana.21578

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.